© jitawit21 / Shutterstock.com
Schwab US Dividend Equity ETF (NYSEARCA: SCHD | SCHD Price Prediction) And Vanguard High Dividend Yield ETF (NYSEARCA: VYM) sit on the shortlist of most income investors. Both entered 2026 with new distributions and updated holdings. The two funds pursue dividends through very different rule sets, and the differences between them are wider than the surface suggests.
Quality Screen vs. Yield Net: How each fund does its calculations
SCHD tracks the Dow Jones US Dividend 100 Index, a quality-weighted screen that seeks cash flow strength, return on equity and 10-year dividend record. Results focused. Bristol-Myers Squibb holds 4.26% of the fund, followed by Merck at 4.14% and ConocoPhillips at 4.10%. Healthcare names BMY, MRK and ABBV occupy three of the top 10 slots, with energy and consumer leading the rest.
VYM casts a wide net. The fund tracks the FTSE High Dividend Yield Index, which offers above average yields of around 400 to 500 without a strict quality gate. That spread softens the single-stock risk and tilts the portfolio toward financials and industrials that SCHD’s screen often filters out.
| lens | SCHD | VYM |
| expense ratio | 0.06% | 0.04% |
| net worth | $71.6 billion | not disclosed |
| index style | Quality + Yield Screen | wide produce basket |
| top zone tilt | healthcare, energy, staples | financial, industrial, healthcare |
Distribution trail tells two stories
SCHD pays steady but smaller per-share checks. The March 2026 delivery came in at $0.2569, followed by the December 2025 delivery at $0.2782. VYM’s payout per share is much larger. VYM’s March 2026 dividend was $0.8617, the December 2025 payment was $0.9474. The dollar difference reflects the share price, not the yield. SCHD closed at $31.54 on May 7, 2026, while VYM closed at $155.16.
Why have the returns varied?
Performance has declined rapidly. VYM has returned 67.14% in five years, much ahead of SCHD’s 46.06%. Year to date: SCHD is up 15.95% while VYM is up 8.7%. In more than a decade, the leader overturned: SCHD’s 229.46% overtook VYM’s 204.10%. Quality screen wins in the long run; The broader basket has won recently.
What am I looking forward to by the end of the year
I’d like to see whether SCHD’s health care-heavy book holds up if drug pricing pressures return, and whether VYM’s financial weight can add to profits if the rate curve flattens. SCHD’s 2024 distributions were unusually large ($0.611 to $0.8241 per quarter), and 2025 looked like a reset, so the next four payments will tell us what the new run rate is.
Why I go with SCHD for Income and VYM for Total Returns
For me the choice depends on the work. If I want a concentrated, quality-checked dividend stream and I’m comfortable with healthcare and energy concentration, SCHD looks neat. If I want broad exposure, slightly lower fees and larger recent capital gains, VYM is a viable option. Retirees who prefer predictable pay increases may favor SCHD. Investors who want yield without sacrificing market breadth will sleep better with VYM. I will not own either in full size. They overlap so much that one slot in the portfolio is enough.